Cargando…

A Real-World Study Comparing Various Antimicrobial Regimens for Bloodstream Infections Caused by Carbapenem-Resistant Gram-Negative Bacilli in a Tertiary Hospital, Shanghai, China, from 2010 to 2017

BACKGROUND: We conducted a real-world analysis of the effectiveness of different antibiotic regimens for bloodstream infections (BSIs) caused by carbapenem-resistant gram-negative bacilli (CR-GNB) in a Chinese population. METHODS: A retrospective observational study was conducted between January 201...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tan, Jiaying, Yu, Wenjin, Wu, Gang, Shen, Jun, Fang, Yong, Zhu, Hechen, Xiao, Qianyi, Peng, Weixia, Lan, Yukun, Gong, Ye
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7382589/ https://www.ncbi.nlm.nih.gov/pubmed/32765019 http://dx.doi.org/10.2147/IDR.S247378

Ejemplares similares

Combination Regimens with Colistin Sulfate versus Colistin Sulfate Monotherapy in the Treatment of Infections Caused by Carbapenem-Resistant Gram-Negative Bacilli
por: Hao, Min, et al.
Publicado: (2022)

Drug Resistance and Molecular Epidemiology of Carbapenem Resistant Gram-negative Bacilli Isolates
por: Naim, Huma, et al.
Publicado: (2018)

Molecular characterization of carbapenem-resistant Gram-negative bacilli clinical isolates in Algeria
por: Bourafa, Nadjette, et al.
Publicado: (2018)

Characteristics of Carbapenem-Resistant Gram-Negative Bacilli in Patients with Ventilator-Associated Pneumonia
por: Mohamed, Amira, et al.
Publicado: (2021)

Molecular characteristics of carbapenem-resistant gram-negative bacilli in pediatric patients in China
por: Yin, Lijun, et al.
Publicado: (2023)

2163. Risk Factors for Carbapenem-Resistant Gram-Negative Bloodstream Infections (BSI) in U.S. Hospitals (2010–2015)
por: Cai, Bin, et al.
Publicado: (2018)

254. Genomic diversity of Gram-negative Bacilli from Bloodstream Infections in Hospitalized Children
por: Blumenthal, Jennifer, et al.
Publicado: (2023)

357 Epidemiology of Carbapenem-Resistant Gram-Negative Bacilli in Georgia, Minnesota, and Oregon – 2012
por: Guh, Alice, et al.
Publicado: (2014)

Synergistic antibacterial activity of silver nanoparticles biosynthesized by carbapenem-resistant Gram-negative bacilli
por: Haji, Sayran Hamad, et al.
Publicado: (2022)

Carbapenem-Resistant Gram-Negative Bacilli Characterization in a Tertiary Care Center from El Bajio, Mexico
por: Nieto-Saucedo, Jose Raul, et al.
Publicado: (2023)

Gram‐ghost bacilli
por: Kuroda, Hirokazu, et al.
Publicado: (2018)

487. Prevalence of Antimicrobial Resistance in Gram-Negative Bacilli Bloodstream Infections at a Tertiary Teaching Hospital in the Dominican Republic
por: Mena Lora, Alfredo J, et al.
Publicado: (2019)

2184. Clinical and Molecular Epidemiology of Carbapenem-Resistant Gram-Negative Bacilli in a Los Angeles Tertiary Medical Center
por: Sanchez, John Michael, et al.
Publicado: (2023)

Predictors of Mortality in Patients with Carbapenem-Resistant Gram-Negative Bacilli or Vancomycin-Resistant Enterococci Bacteremia
por: Shi, Hye Jin, et al.
Publicado: (2020)

Phenotypic characterization of carbapenem non-susceptible gram-negative bacilli isolated from clinical specimens
por: Abdeta, Abera, et al.
Publicado: (2021)

Evaluation of different methods for in vitro susceptibility testing of colistin in carbapenem resistant Gram-negative bacilli
por: Rout, Bidyutprava, et al.
Publicado: (2023)

1191. Prevalence and Microbiology of Carbapenem Resistance Among Six Gram-Negative Pathogens in Bloodstream Infections in US Hospitals, 2010–2015
por: Lodise, Thomas P, et al.
Publicado: (2018)

212. Effectiveness of Empirical Piperacillin/tazobactam Compared to Cefepime for Bloodstream Infection Caused by Gram-Negative Bacilli
por: Ho Lee, Young, et al.
Publicado: (2023)

Routine detection of carbapenem-resistant gram-negative bacilli in clinical laboratories: A review of current challenges
por: Al-Zahrani, Ibrahim A.
Publicado: (2018)

Prevalence and Molecular Mechanisms of Carbapenem Resistance among Gram-Negative Bacilli in Three Hospitals of Northern Lebanon
por: Rima, Mariam, et al.
Publicado: (2022)

Clinical efficacy and drug resistance of ceftazidime-avibactam in the treatment of Carbapenem-resistant gram-negative bacilli infection
por: Xiao, Shuang, et al.
Publicado: (2023)

Predictive Score for Carbapenem-Resistant Gram-Negative Bacilli Sepsis: Single-Center Prospective Cohort Study
por: Gomes, Marisa Zenaide Ribeiro, et al.
Publicado: (2022)

Characterization of Carbapenemase- and ESBL-Producing Gram-Negative Bacilli Isolated from Patients with Urinary Tract and Bloodstream Infections
por: Tickler, Isabella A., et al.
Publicado: (2023)

In Vivo Efficacy of Cefiderocol against Carbapenem-Resistant Gram-Negative Bacilli in Murine Urinary Tract Infection Models
por: Matsumoto, Shuhei, et al.
Publicado: (2017)

The Simplified Carbapenem Inactivation Method (sCIM) for Simple and Accurate Detection of Carbapenemase-Producing Gram-Negative Bacilli
por: Jing, Xiaopeng, et al.
Publicado: (2018)

Impact of an Antimicrobial Stewardship Program on the Incidence of Carbapenem Resistant Gram-Negative Bacilli: An Interrupted Time-Series Analysis
por: López-Viñau, Teresa, et al.
Publicado: (2021)

Treatments and Predictors of Mortality for Carbapenem-Resistant Gram-Negative Bacilli Infections in Malaysia: A Retrospective Cohort Study
por: Abubakar, Usman, et al.
Publicado: (2022)

Ceftazidime/avibactam combined with colistin: a novel attempt to treat carbapenem-resistant Gram-negative bacilli infection
por: Zheng, Zihao, et al.
Publicado: (2023)

Molecular epidemiology of carbapenem resistant gram-negative bacilli from infected pediatric population in tertiary - care hospitals in Medellín, Colombia: an increasing problem
por: Vanegas, Johanna M., et al.
Publicado: (2016)

Activities of Cefiderocol with Simulated Human Plasma Concentrations against Carbapenem-Resistant Gram-Negative Bacilli in an In Vitro Chemostat Model
por: Matsumoto, Shuhei, et al.
Publicado: (2020)

Risk factors for and clinical outcomes of carbapenem non-susceptible gram negative bacilli bacteremia in patients with acute myelogenous leukemia
por: Shin, Dong Hoon, et al.
Publicado: (2020)

616. Evaluation of In Vitro Susceptibility to Ceftazidime/Avibactam of Clinical Isolates of Carbapenem Nonsusceptible Gram-Negative Bacilli from Colombia
por: Appel, Tobias M, et al.
Publicado: (2019)

Treatment of Carbapenem-Resistant Multidrug-Resistant Gram-Negative Bacilli with Intracerebroventricular Injection of Polymyxin B: A Retrospective Study
por: Liu, Dongsheng, et al.
Publicado: (2022)

Molecular Characteristics of Escherichia coli Causing Bloodstream Infections During 2010–2015 in a Tertiary Hospital, Shanghai, China
por: Li, Dan, et al.
Publicado: (2021)

Mechanisms of antimicrobial resistance in Gram-negative bacilli
por: Ruppé, Étienne, et al.
Publicado: (2015)

Defining multidrug resistance in Gram-negative bacilli
por: Kumar, V. Anil, et al.
Publicado: (2015)

Multi-locus sequence typing (MLST) of non-fermentative Gram-negative bacilli isolated from bloodstream infections in southern Poland
por: Chmielarczyk, Agnieszka, et al.
Publicado: (2017)

Increasing Carbapenem-Resistant Gram-Negative Bacilli and Decreasing Metallo-β-Lactamase Producers over Eight Years from Korea
por: Lee, Yangsoon, et al.
Publicado: (2015)

Boronic acid disk diffusion for the phenotypic detection of polymerase chain reaction-confirmed, carbapenem-resistant, gram-negative bacilli isolates
por: Elsherif, Rasha, et al.
Publicado: (2016)

Detection and characterization of carbapenem resistant Gram‐negative bacilli isolates recovered from hospitalized patients at Soba University Hospital, Sudan
por: Elbadawi, Hana S., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_f19ur5r706ckve1bhl4gfvd5ej